Immune to Cancer: The CRI Blog
-
Cancer Cabinet Declares Updates to President Biden’s Cancer Moonshot Initiative
U.S. President Joe Biden’s administration is following through on last year’s commitment to reignite the White House… -
Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field
iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill… -
Join #TeamCRI and Plan Your Own Tailgate for a Purpose
The Cancer Research Institute (CRI) now has a new way to create a world immune to cancer,… -
CRI’s Dr. Jill O’Donnell-Tormey Explains Five Things You Need to Know About Cancer Vaccines
Vaccines had been effective at preventing viral and bacterial-borne viruses for two hundred years before the first… -
Recent Innovations and Challenges in Fighting Blood Cancers
The term “blood cancer” encompasses several types of cancer, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS),… -
A CRI Board Member’s Father was Diagnosed with Cancer – He Quickly Raised Over $150,000 for Research
It started with an idea. Yacov Arnopolin wanted to raise money for a cause that was close… -
Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies
CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, recently spoke with ecancer about recent developments… -
Sarcomas: Unique Cancers that Merit Further Attention and Research
Sarcomas are unique compared to other types of cancer variations. In contrast to carcinomas, which arise from… -
CRI’s Wear White Luncheon Raises Over $30,000
By Rebecca Jensen The Cancer Research Institute held its fourth annual Wear White Luncheon, hosted by Mary…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.